Skip to content Skip to footer
Subscribe Now
EVENTS

HLTH Europe 2026: Key Highlights & Industry Insights 

Shots  • HLTH Europe 2026 brought together over 5,000 healthcare leaders, investors, policymakers, payers, providers, pharmaceutical executives, and digital health innovators in Amsterdam to explore the future of healthcare innovation.  • Healthcare has a paradox: brilliant point solutions are failing not because they don't work, but because they can't talk to each other. A patient…
June 22, 2026

Read more

INSIGHTS+

The US FDA New Drug Approvals in April 2026 

Shots:  Approval activity continued strongly into April 2026, with the US FDA authorizing two significant therapies across metabolic disease and infectious disease, reinforcing the agency’s focus on chronic disease management, long-term treatment innovation, and broader patient access.  Two notable therapies achieved regulatory clearance: Eli Lilly’s Foundayo for weight loss in obese or overweight adults with weight-related conditions,…
May 12, 2026

Read more

INSIGHTS+

The US FDA New Drug Approvals in January 2026 

Shots:  Approval numbers were lower, but the impact remained strong the FDA cleared one new drug in January 2026 versus three in January 2025, reflecting continued innovation in areas of high unmet need  Zycubo from Sentynl Therapeutics was approved for pediatric Menkes disease, offering a targeted treatment for this rare, life-threatening genetic copper deficiency disorder  Clinical results were striking, showing…
February 10, 2026

Read more

INSIGHTS+

Know Your Investor: Cormorant Asset Management (September’25 Edition) 

Shots:  Welcome to the September edition of Know Your Investor, featuring leading investors fuelling healthcare & life sciences  This edition spotlights Cormorant Asset Management, an investment firm focused on biotechnology and healthcare companies  In 2024, Cormorant completed 31 investments ~$3.88B, spanning PIPEs, private financings, IPO, and venture rounds. For the full report, contact us at…
September 4, 2025

Read more

INSIGHTS+

Know Your Investor: Venrock Healthcare Capital Partners (August’25 Edition)   

Shots:     Welcome to the August edition of Know Your Investor, featuring leading venture capital firms fuelling innovation in healthcare and life sciences  This edition spotlights Venrock Healthcare Capital Partners, a venture capital fund focused on investments in both publicly and privately held healthcare companies  In 2024, Venrock Healthcare Capital Partners invested approximately $4.56B across six…
August 7, 2025

Read more

20 Innovative Digital Therapeutics Companies of 2025
TOP 20

20 Innovative Digital Therapeutics Companies of 2025 

Shots:   The integration of innovative technologies in healthcare, such as digital health platforms and AI-enabled applications, is transforming the way diseases are detected, diagnosed, treated, and prevented  The global Digital Health market is expected to reach $197.88B in 2025 and grow at a CAGR of 6.88%, reaching $258.25B by 2029  PharmaShots presents a concise report…
July 3, 2025

Read more

Hlth
EVENTS

2025 | HLTH Europe: 16-19 June | Amsterdam

HLTH Europe is the continent’s #1 healthcare innovation event. Following an enormously successful first event in 2024 and the exponential growth of HLTH in the US, this landmark event is where global expertise meets local insight to address Europe's unique healthcare challenges and opportunities. Don’t miss out on this opportunity to connect with like-minded individuals…
May 6, 2025

Read more

Thoughtspot_Saurabh_Chaubey
THOUGHTSPOT

Role of Digital Twin Technology in Healthcare

Shots:  Developments in healthcare technologies are setting new standards at present and encouraging exploration into emerging technologies to advance care and enhance the lives of patients globally  Digital Twins are virtual replicas of objects, individuals, or systems spanning their life cycles  The article introduces the role of digital twins in the healthcare system, the advantages,…
March 19, 2025

Read more

Load more